Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The closing price of Anixa Biosciences Inc (NASDAQ: ANIX) was $3.26 for the day, down -8.94% from the previous closing price of $3.58. In other words, the price has decreased by -$8.94 from its previous closing price. On the day, 0.75 million shares were traded. ANIX stock price reached its highest trading level at $3.5991 during the session, while it also had its lowest trading level at $3.25.
Ratios:
Our analysis of ANIX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 8.45 and its Current Ratio is at 8.45. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In the most recent recommendation for this company, Maxim Group on March 21, 2025, initiated with a Buy rating and assigned the stock a target price of $10.
On December 23, 2022, Chardan Capital Markets started tracking the stock assigning a Buy rating and target price of $8.
On April 12, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $11.H.C. Wainwright initiated its Buy rating on April 12, 2021, with a $11 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jul 31 ’25 when Titterton Lewis H jr bought 10,000 shares for $3.08 per share. The transaction valued at 30,800 led to the insider holds 953,334 shares of the business.
KUMAR AMIT bought 5,000 shares of ANIX for $15,800 on Jul 30 ’25. The Chief Executive Officer now owns 579,925 shares after completing the transaction at $3.16 per share. On Jul 18 ’25, another insider, Baskies Arnold M, who serves as the Director of the company, bought 5,000 shares for $3.39 each. As a result, the insider paid 16,950 and bolstered with 125,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ANIX now has a Market Capitalization of 107309144 and an Enterprise Value of 90309144.
Stock Price History:
The Beta on a monthly basis for ANIX is 0.50, which has changed by 0.30656934 over the last 52 weeks, in comparison to a change of 0.12838376 over the same period for the S&P500. Over the past 52 weeks, ANIX has reached a high of $5.46, while it has fallen to a 52-week low of $2.07. The 50-Day Moving Average of the stock is -24.55%, while the 200-Day Moving Average is calculated to be -2.36%.
Shares Statistics:
ANIX traded an average of 295.29K shares per day over the past three months and 722830 shares per day over the past ten days. A total of 32.82M shares are outstanding, with a floating share count of 31.14M. Insiders hold about 5.40% of the company’s shares, while institutions hold 16.59% stake in the company. Shares short for ANIX as of 1764288000 were 565273 with a Short Ratio of 1.91, compared to 1761868800 on 573380. Therefore, it implies a Short% of Shares Outstanding of 565273 and a Short% of Float of 1.76.
Earnings Estimates
. The current rating of Anixa Biosciences Inc (ANIX) reflects the combined expertise of 1.0 analysts actively engaged in assessing its market performance.The consensus estimate for the next quarter is -$0.1, with high estimates of -$0.1 and low estimates of -$0.1.
Analysts are recommending an EPS of between -$0.35 and -$0.35 for the fiscal current year, implying an average EPS of -$0.35. EPS for the following year is -$0.38, with 2.0 analysts recommending between -$0.38 and -$0.38.
